Dianthus Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 4.44 M | $96.78 M | 0.82% | 12.97% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 2.87 M | $62.63 M | -1.52% | 8.39% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 2.70 M | $58.88 M | 0.00% | 7.89% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 2.69 M | $58.64 M | -10.74% | 7.86% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 2.11 M | $46.00 M | 20.81% | 6.16% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.87 M | $40.69 M | -20.00% | 5.45% |
VR ADVISER, LLC | 02/14/2025 | 1.74 M | $38.03 M | 0.00% | 5.10% |
BLACKROCK, INC. | 02/07/2025 | 1.65 M | $35.99 M | 0.37% | 4.82% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 1.50 M | $32.74 M | 100.00% | 4.39% |
BRAIDWELL LP | 02/14/2025 | 1.21 M | $26.30 M | 144.40% | 3.52% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.16 M | $25.28 M | 13.35% | 3.39% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 1.09 M | $23.61 M | 14.36% | 3.17% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.08 M | $23.44 M | 172.15% | 3.14% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 1.03 M | $22.40 M | -16.56% | 3.00% |
02/14/2025 | 763,471 | $16.64 M | 100.00% | 2.23% | |
RTW INVESTMENTS, LP | 02/14/2025 | 666,667 | $14.53 M | 0.00% | 1.95% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 486,263 | $10.60 M | 0.24% | 1.42% |
CITADEL ADVISORS LLC | 02/14/2025 | 422,038 | $9.20 M | 611.69% | 1.23% |
WOODLINE PARTNERS LP | 02/14/2025 | 300,504 | $6.55 M | 19.96% | 0.88% |
GREAT POINT PARTNERS LLC | 02/14/2025 | 275,000 | $6.00 M | 0.00% | 0.80% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 264,692 | $5.77 M | 0.00% | 0.77% |
NORTHERN TRUST CORP | 02/14/2025 | 245,523 | $5.35 M | 21.19% | 0.72% |
ALPHABET INC. | 02/07/2025 | 208,697 | $4.55 M | 0.00% | 0.61% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 193,600 | $4.22 M | -55.77% | 0.57% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 180,000 | $3.92 M | 100.00% | 0.53% |
MORGAN STANLEY | 02/14/2025 | 116,049 | $2.53 M | 72.47% | 0.34% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 114,000 | $2.49 M | -24.00% | 0.33% |
ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 106,434 | $2.32 M | 100.00% | 0.31% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 90,436 | $1.97 M | 160.22% | 0.26% |
WALLEYE CAPITAL LLC | 02/13/2025 | 82,890 | $1.81 M | 176.30% | 0.24% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 78,173 | $1.70 M | -11.20% | 0.23% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 65,851 | $1.44 M | 0.00% | 0.19% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 60,337 | $1.32 M | 12.18% | 0.18% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 43,996 | $959,113 | 3.85% | 0.13% |
RHUMBLINE ADVISERS | 01/30/2025 | 35,933 | $783,335 | 3.80% | 0.11% |
HIGHVISTA STRATEGIES LLC | 02/14/2025 | 31,387 | $684,237 | 58.46% | 0.09% |
CITIGROUP INC | 02/12/2025 | 30,542 | $665,815 | 75.59% | 0.09% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 28,459 | $620,406 | -7.14% | 0.08% |
ALLOSTERY INVESTMENTS LP | 02/14/2025 | 25,000 | $545,000 | 100.00% | 0.07% |
ALPS ADVISORS INC | 02/13/2025 | 23,932 | $521,718 | 7.33% | 0.07% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 20,788 | $453,178 | 0.00% | 0.06% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 17,683 | $385,489 | -85.11% | 0.05% |
BESSEMER GROUP INC | 02/13/2025 | 14,829 | $323,000 | 0.00% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 14,716 | $320,474 | 2.45% | 0.04% |
POINT72 (DIFC) LTD | 02/14/2025 | 14,013 | $305,483 | 12.34% | 0.04% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 13,026 | $283,967 | 50.49% | 0.04% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 12,319 | $268,554 | 23.73% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 11,883 | $259,049 | -7.02% | 0.03% |
SQUAREPOINT OPS LLC | 02/14/2025 | 11,081 | $241,566 | -26.92% | 0.03% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 10,601 | $231,102 | -5.26% | 0.03% |
Dianthus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 72 institutional investors and hedge funds held shares of Dianthus Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 4.44 M
Avidity Partners Management LP: 2.87 M
Fairmount Funds Management LLC: 2.7 M
Bain Capital Life Sciences Investors, LLC: 2.69 M
Octagon Capital Advisors LP: 2.11 M
RA CAPITAL MANAGEMENT, L.P.: 1.87 M
100.19% of Dianthus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.05 M shares in the last 24 months. This purchase volume represents approximately $581.96 M in transactions.